FiercePharmaAsia—JSR’s $400M Crown buy, Orchid buyout bids, Tessa’s $80M funding

21st December 2017 Uncategorised 0

Japan’s JSR has snapped up Taiwan-based CRO Crown Biosciences for $400 million, Aurobindo and Dr. Reddy’s responded to a report on their bids for Orchid Pharma, Singapore’s Tessa raised $80 million for a T-cell therapy push, and more.

More: FiercePharmaAsia—JSR’s 0M Crown buy, Orchid buyout bids, Tessa’s M funding
Source: fierce